Multiple sclerosis
Multiple sclerosis (MS) is a condition of the central nervous system that affects the brain and spinal cord. Symptoms vary widely and may include visual problems, numbness, weakness, balance problems, fatigue and cognitive changes.
At a glance
Quick facts
- Category
- Chronic central nervous system disease
- Main systems
- Brain · spinal cord · optic nerves
- Course
- Relapsing and/or progressive patterns
- Diagnosis
- Neurologic assessment + MRI
- Global average diagnosis age
- 32 years (Atlas of MS 2020)
- Treatment
- Disease modification + symptom care
Dr. Fitsum Admasu Tinsae
General Medicine · Public Health · Digital Health
Reviewed for clinical accuracy, clarity and practical public-health context.
Names & terminology
How this entity may be named or searched
- Canonical name
- Multiple sclerosis
- Abbreviation
- MS
- Historical term
- Disseminated sclerosis appears in older literature and is not the preferred modern name.
- Related concepts
- Clinically isolated syndrome and radiologically isolated syndrome are related diagnostic concepts, not simple synonyms.
Structured entity profile
Clinical profile
What is multiple sclerosis?
Multiple sclerosis is a condition affecting the brain and spinal cord. It can cause a wide range of neurological symptoms, and the pattern can include relapses and remissions or gradual progression. There is no single symptom pattern that fits everyone. [1]
Symptoms
Possible symptoms include fatigue, visual disturbance or eye pain, numbness or tingling, weakness, balance or coordination problems, muscle stiffness or spasms, bladder symptoms and problems with memory or concentration. These symptoms are not specific to MS and can have other causes. [1]
SYMPTOM MATRIX
How multiple sclerosis may present
Symptoms can appear in many combinations and may come and go or progress over time.
- Fatigue
- Visual disturbance
- Numbness or tingling
- Weakness
- Balance or coordination problems
- Muscle stiffness or spasms
- Bladder or bowel symptoms
- Pain
- Cognitive changes
- Mood or sleep problems
- Sudden major loss of vision
- New severe weakness
- New inability to walk
- Acute neurologic symptoms with impaired consciousness
New or rapidly worsening neurologic symptoms need clinical assessment; not every symptom change represents an MS relapse.
Diagnosis
Diagnostic pathway
How multiple sclerosis is diagnosed
Neurologists combine clinical history, examination and evidence from MRI and sometimes cerebrospinal fluid or laboratory testing.
MS diagnosis requires specialist interpretation; there is no single stand-alone screening test.
Treatment
Treatment depends on the type of MS, disease activity and symptoms. It may include disease-modifying therapies to reduce relapses or progression, corticosteroids for selected relapses, and treatments for symptoms such as spasticity, pain, bladder problems or fatigue. Rehabilitation and multidisciplinary support are often important. [1] [2]
There is currently no cure for multiple sclerosis, but treatment can reduce relapses, slow disease activity or progression in appropriate patients, and help manage symptoms and quality of life.
Treatment & care hub
MS care combines disease modification, relapse care and rehabilitation
Treatment depends on disease course, activity, symptoms, comorbidities, pregnancy plans and individual preferences.
Disease-modifying therapy
DMTs aim to reduce relapses and/or new disease activity; selection is individualized.
Relapse treatment
Corticosteroids may be used for selected clinically significant relapses.
Symptom management
Spasticity, pain, bladder symptoms, fatigue and mood may require targeted treatment.
Rehabilitation & support
Physiotherapy, occupational therapy, cognitive support and social care can help maintain function.
Treatment choices require specialist assessment and ongoing monitoring.
Living with MS
People with MS may need different kinds of support over time, including physiotherapy, occupational therapy, mobility aids, fatigue management, cognitive rehabilitation and psychological support. Care is usually individualized and reviewed as needs change. [1]
Geo data · Atlas of MS
Multiple sclerosis around the world
The main tabs compare the same epidemiologic concept: people living with MS. Country resource data are kept outside the comparison when a national MS count is unavailable.
MS specialist neurologists
Atlas of MS country factsheet; national number of people with MS is not available in the current factsheet.
Atlas of MS ↗Common questions
A relapse means new or worsening neurological symptoms lasting more than 24 hours after a stable period, with infection and other explanations considered and excluded where appropriate.
Frequently asked questions
No. MS can follow different patterns, including relapsing disease and progressive forms.
No. Diagnosis uses the clinical history, examination, MRI and other evidence interpreted by a specialist.
There is currently no cure, but disease-modifying and symptom treatments can substantially change the course and impact of the condition.
A relapse is a new or worsening neurological episode attributable to MS after a period of stability; clinicians also exclude other causes such as infection.
Yes. Some people experience problems with memory, concentration or processing speed, while others do not.
Sources
Clinical statements in this reference are linked to named public-health, regulatory or guideline sources.
- 1. NHS. Multiple sclerosis — symptoms, diagnosis and treatment. Source ↗
- 2. NICE. Multiple sclerosis in adults: management (NG220), updated June 2026. Source ↗
- 3. MS International Federation. Atlas of MS 2020 — epidemiology report. Source ↗
- 4. MS International Federation. Atlas of MS — latest global and country epidemiology / clinical-management data. Source ↗
This article is based on trusted medical sources and has undergone clinician review. It is not a substitute for personalized medical advice.
MRI is a key investigation in multiple sclerosis, but it is interpreted together with the neurological history, examination and other evidence rather than used as a stand-alone diagnosis.